FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

385287007: Parenteral dose form (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3620889014 Parenteral dose form (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3620890017 Parenteral dose form en Synonym Active Entire term case insensitive SNOMED CT core module

78 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Parenteral dose form Is a Type of drug preparation false Inferred relationship Existential restriction modifier
Parenteral dose form Is a Dose form by site prepared for false Inferred relationship Existential restriction modifier
Parenteral dose form Is a Pharmaceutical dose form true Inferred relationship Existential restriction modifier
Parenteral dose form Has dose form intended site Parenteral true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Steriflex No.30 potassium chloride 0.2% (potassium 13.3mmol/500ml) / glucose 4% / sodium chloride 0.18% solution for injection 500ml bags (Fresenius Kabi Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Steriflex No.28 potassium chloride 0.2% (potassium 13.3mmol/500ml) / sodium chloride 0.9% solution for injection 500ml bags (Fresenius Kabi Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Steriflex No.45 glucose 5% / sodium chloride 0.45% solution for injection 500ml bags (Fresenius Kabi Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Steriflex No.45 glucose 5% / sodium chloride 0.45% solution for injection 1litre bags (Fresenius Kabi Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Intraven potassium chloride 0.2% (potassium 13.3mmol/500ml) / sodium chloride 0.9% solution for injection 500ml bags (Ivex Pharmaceuticals) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Scandonest special 2% solution for injection 2.2ml cartridges (Deproco UK Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Rexocaine 2% injection 2.2ml cartridges (Deproco UK Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Cyclizine tartrate 50mg/1ml / Morphine tartrate 15mg/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Cyclizine tartrate 50mg/1ml / Morphine tartrate 10mg/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Amphotericin (liposomal) 100mg powder for solution for injection vials Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Cyclizine tartrate 50mg/1ml / Morphine tartrate 10mg/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Cyclizine tartrate 50mg/1ml / Morphine tartrate 15mg/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 500mg capsules (Special Order) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Amphotericin (lipid formulation) 50mg powder for solution for injection vials Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Cyclizine tartrate 50mg/1ml / Morphine tartrate 10mg/1ml solution for injection ampoules (Unichem Plc) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Cyclizine tartrate 50mg/1ml / Morphine tartrate 15mg/1ml solution for injection ampoules (Unichem Plc) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Steriflex No.29 potassium chloride 0.2% (potassium 13.3mmol/500ml) / glucose 5% solution for injection 500ml bags (Fresenius Kabi Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Carbostesin-adrenaline 0.25% / 25micrograms/5ml (1 in 200,000) solution for injection ampoules (AstraZeneca) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Carbostesin-adrenaline 0.25% / 100micrograms/20ml (1 in 200,000) solution for injection ampoules (AstraZeneca) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Carbostesin-adrenaline 0.5% / 25micrograms/5ml (1 in 200,000) solution for injection ampoules (AstraZeneca) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Carbostesin-adrenaline 0.5% / 100micrograms/20ml (1 in 200,000) solution for injection ampoules (AstraZeneca) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Bupivacaine 25mg/10ml / Adrenaline 50micrograms/10ml (1 in 200,000) solution for injection ampoules (Goldshield Pharmaceuticals Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Bupivacaine 50mg/10ml / Adrenaline 50micrograms/10ml (1 in 200,000) solution for injection ampoules (Goldshield Pharmaceuticals Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Sodium ascorbate / Ascorbic acid oral powder 11g sachets sugar free Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Potassium chloride 0.3% (potassium 20mmol/500ml) / Glucose 5% / Sodium chloride 0.45% solution for injection 500ml bags (Special Order) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Potassium chloride 0.3% (potassium 20mmol/500ml) / Glucose 10% solution for injection 500ml bags (Special Order) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Potassium chloride 0.6% (potassium 40mmol/500ml) / Glucose 5% solution for injection 500ml bags (Special Order) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Potassium chloride 0.6% (potassium 40mmol/500ml) / Sodium chloride 0.9% solution for injection 500ml bags (Special Order) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Potassium chloride 0.45% (potassium 60mmol/1litre) / Sodium chloride 0.9% solution for injection 1litre bags (Special Order) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Potassium chloride 0.15% (potassium 10mmol/500ml) / Glucose 10% solution for injection 500ml bags (Special Order) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Potassium chloride 3% (potassium 40mmol/100ml) / Sodium chloride 0.9% solution for injection 100ml bags (Special Order) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Potassium chloride 1.5% (potassium 20mmol/100ml) / Sodium chloride 0.9% solution for injection 100ml bags (Special Order) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Potassium chloride 7.5% (potassium 50mmol/50ml) / Sodium chloride 0.9% solution for injection 50ml bags (Special Order) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Glucose 5% / Sodium chloride 0.9% solution for injection 500ml bags (A A H Pharmaceuticals Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Glucose 4% / Sodium chloride 0.9% solution for injection 1litre bags (A A H Pharmaceuticals Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 1.25g/5ml oral solution (Special Order) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 1.575g/5ml oral solution (Special Order) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 1.5g/5ml oral solution (Special Order) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 1.6g/5ml oral solution (Special Order) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 1.75g/5ml oral solution (Special Order) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 1.83g/5ml oral solution (Special Order) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 1g/5ml oral solution (Special Order) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 250mg/5ml oral solution (Special Order) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 400mg/5ml oral solution (Special Order) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 470mg/5ml oral solution (Special Order) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 500mg/5ml oral solution (Special Order) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 50mg/5ml oral solution (Special Order) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 600mg/5ml oral solution (Special Order) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 700mg/5ml oral solution (Special Order) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 750mg/5ml oral solution (Special Order) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 800mg/5ml oral solution (Special Order) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Glucose 4% / Sodium chloride 0.18% solution for infusion 500ml Macoflex bags (Maco Pharma (UK) Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Glucose 4% / Sodium chloride 0.18% solution for infusion 1litre Macoflex bags (Maco Pharma (UK) Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Ferinject 100mg/2ml solution for injection vials (Syner-Med (Pharmaceutical Products) Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Ferinject 500mg/10ml solution for injection vials (Syner-Med (Pharmaceutical Products) Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Solu-Medrone 500mg powder and solvent for solution for injection vials (Waymade Healthcare Plc) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Amphocil 100mg powder for solution for injection vials (Cambridge Laboratories) Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Amphocil 50mg powder for solution for injection vials (Cambridge Laboratories) Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
AmBisome 50mg powder for solution for injection vials (Gilead Sciences) Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Moviprep B oral powder 11g sachets (Norgine Pharmaceuticals Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Synovial fluid 48mg/6ml injection pre-filled syringes Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Synvisc ONE (Hylan G-F20) 48mg/6ml injection pre-filled syringes (Genzyme Therapeutics Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Mannitol 100g/500ml solution for injection polyethylene bottles Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Powder and suspension for suspension for injection Is a True Parenteral dose form Inferred relationship Existential restriction modifier
Glucose 4% / Sodium chloride 0.18% infusion 1litre Viaflo bags (Baxter Healthcare Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Glucose 4% / Sodium chloride 0.18% infusion 500ml Viaflo bags (Baxter Healthcare Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Glucose 2.5% / Sodium chloride 0.45% infusion 500ml Viaflo bags (Baxter Healthcare Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Potassium chloride 0.2% (potassium 13.3mmol/500ml) / Sodium chloride 0.9% infusion 500ml Macoflex bags (Maco Pharma (UK) Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Synovial fluid 75mg/3ml injection pre-filled syringes Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Arthrum 75mg/3ml injection pre-filled syringes (Dee Pharmaceuticals Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Methylprednisolone sodium succinate 500mg powder and solvent for solution for injection vials (Kent Pharma (UK) Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Methylprednisolone sodium succinate 1g powder and solvent for solution for injection vials (Kent Pharma (UK) Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Lignospan Special 20mg/ml / 12.5micrograms/ml solution for injection 2.2ml cartridges (Septodont Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Methylprednisolone sodium succinate 500mg powder and solvent for solution for injection vials (A A H Pharmaceuticals Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Methylprednisolone sodium succinate 1g powder and solvent for solution for injection vials (A A H Pharmaceuticals Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate powder (Special Order) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Solution for cardioplegia Is a True Parenteral dose form Inferred relationship Existential restriction modifier
Methylprednisolone sodium succinate 40mg powder and solvent for solution for injection vials (A A H Pharmaceuticals Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Powder and solvent for prolonged-release suspension for injection Is a True Parenteral dose form Inferred relationship Existential restriction modifier
Gas and solvent for dispersion for injection/infusion Is a True Parenteral dose form Inferred relationship Existential restriction modifier
Powder and solvent for solution for infusion Is a True Parenteral dose form Inferred relationship Existential restriction modifier
Powder and solvent for suspension for infusion Is a True Parenteral dose form Inferred relationship Existential restriction modifier
Dispersion for infusion Is a False Parenteral dose form Inferred relationship Existential restriction modifier
Colloidal suspension for injection Is a False Parenteral dose form Inferred relationship Existential restriction modifier
Prolonged-release solution for injection Is a True Parenteral dose form Inferred relationship Existential restriction modifier

Start Previous Page 26 of 26

This concept is not in any reference sets

Back to Start